Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
Swedish Cancer Society, Confederation of Regional Cancer Centres, and Swedish governmental funding for clinical research.
Authors
- Ingvar Andersson (ORCID: https://orcid.org/0000-0001-5309-4037)
- Solveig Hofvind (ORCID: https://orcid.org/0000-0003-0178-8939)
- David Schmidt (ORCID: https://orcid.org/0000-0001-7728-2884)
- Hanna Sartor (ORCID: https://orcid.org/0000-0002-1116-5199)
- Oskar Hagberg (ORCID: https://orcid.org/0000-0001-5997-9813)
- Viktoria Josefsson
- Aldana Rosso (ORCID: https://orcid.org/0000-0001-6603-2855)
- Kristina Lång (ORCID: https://orcid.org/0000-0001-9250-1897)
- Anna-Maria Larsson
- Veronica Hernström
Institutions
- Lund University (SE)
- Cancer Registry of Norway (NO)
- Skåne University Hospital (SE)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- The Lancet Digital Health
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1016/s2589-7500(24)00267-x
- Citations
- 89
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 220.81